You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 286 No. 19, November 21, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  From the Archives Journals: Abstract and Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antioxidants and Zinc to Prevent Progression of Age-Related Macular Degeneration

Commentary by Lee M. Jampol, MD; Frederick L. Ferris III, MD

JAMA. 2001;286(19):2466-2468.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

ARCHIVES OF OPHTHALMOLOGY

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8

Age-Related Eye Disease Study Research Group

Background  Observational and experimental data suggest that antioxidant and/or zinc supplements may delay progression of age-related macular degeneration (AMD) and vision loss.

Objective  To evaluate the effect of high-dose vitamins C and E, beta carotene, and zinc supplements on AMD progression and visual acuity.

Design  The Age-Related Eye Disease Study, an 11-center double-masked clinical trial, enrolled participants in an AMD trial if they had extensive small drusen, intermediate drusen, large drusen, noncentral geographic atrophy, or pigment abnormalities in 1 or both eyes, or advanced AMD or vision loss due to AMD in 1 eye. At least 1 eye had best-corrected visual acuity . . . [Full Text of this Article]

Commentary

Author Affiliations: Department of Ophthalmology, Northwestern University Medical School, Chicago, Ill (Dr Jampol); and National Eye Institute, Bethesda, Md (Dr Ferris).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Does eating particular diets alter the risk of age-related macular degeneration in users of the Age-Related Eye Disease Study supplements?
Chiu et al.
Br J Ophthalmol 2009;93:1241-1246.
ABSTRACT | FULL TEXT  

Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis
Chong et al.
BMJ 2007;335:755-755.
ABSTRACT | FULL TEXT  

The {beta}-Adrenergic Receptor Antagonist Metipranolol Blunts Zinc-Induced Photoreceptor and RPE Apoptosis.
Osborne and Wood
IOVS 2006;47:3178-3186.
ABSTRACT | FULL TEXT  

Cancer Prevention Science and Practice
Lippman and Hong
Cancer Res. 2002;62:5119-5125.
FULL TEXT  

Toxic Effects Associated With Consumption of Zinc
Igic et al.
Mayo Clin Proc. 2002;77:713-716.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.